Skip to main content
. 2021 May 25;10(6):630. doi: 10.3390/antibiotics10060630

Table 4.

Age and comorbidities in comparison groups.

Comorbid Condition Combined Therapy (n = 175) Monotherapy (n = 145) p Value
No of comorbidities Median (IQR) 2 (1–3) 2 (0-3) 0.29
Age Median (IQR) 62.72 (39.2–73.2) 62.84 (38.5–76.3) 0.80
Diabetes mellites 77 44% 54 37% 0.22
Chronic renal failure 36 21% 22 15% 0.21
Active malignancy 7 4% 7 5% 0.72
Immuno-suppressed 4 2% 5 3% 0.53
Chronic Cardiac Diseases 100 57% 78 54% 0.55
Chronic Resp. Disease 20 11% 15 10% 0.76